Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 8Completed 4Active not recruiting 4Terminated 2Enrolling by invitation 1

Sponsor Class

NIH 2OTHER 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Agnosia 1

Interventions

pembrolizumab 74Cyclophosphamide 49Cisplatin 46Nivolumab 36Paclitaxel 33Radiotherapy 32Carboplatin 31Gemcitabine 30Docetaxel 27Dexamethasone 24atezolizumab 22Bevacizumab 21Blood Specimen Collection 20Lenalidomide 19Etoposide 19Radiosurgery 18Magnetic Resonance Spectroscopy 18Leucovorin 18Fluorouracil 18Doxorubicin 18fludarabine 17Surveys and Questionnaires 17Rituximab 17Vincristine 16Oxaliplatin 16Cytarabine 16Ipilimumab 15palbociclib 14durvalumab 14Radiotherapy, Intensity-Modulated 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Acetaminophen × 90 days × Clear all
NCT04165096 2026-05-13

MK-3475-01C

Merck Sharp & Dohme LLC

Phase 2 Completed
128 enrolled 14 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 21 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02439034 2026-03-16

KETOCOL

Centre Oscar Lambret

Phase 2 Completed
68 enrolled
GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡